脂联素与代谢综合征的研究进展(4)

　　［5］ YAMAUCHI T, KAMON J, ITO Y, et al. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects［J］. Nature,2003, 423:762-769.

　　［6］ CHINETTI G Z, FRUCHART J C, STAELS B. Expression of adiponectin receptors in human macrophages and regulation by agonists of the nuclear receptors PPARalpha, PPARgamma, and LXR［J］. Biochem Biophys Res Commun,2004,314:151-158.

　　［7］ HUG C, WANG J, AHMAD N S, et al.T?cadherin is a receptor for hexameric and high?molecular?weight forms of Acrp30/adiponectin［J］. Proc Natl Acad Sci USA,2004,101:10308-10313.

　　［8］ ARITA Y, KIHARA S, OUCHI N, et al. Paradoxical decrease of an adipose?specific protein, adiponectin,in obesity Biochem［J］. Biophys Res Commun,1999,257: 79-83.

　　［9］ MOTOSHIMA H, WU X, SINHA M K,et al.Differential regulation of adiponectin secretion from cultured human omental and subcutaneous adipocytes: effects of insulin and rosiglitazone［J］. J Clin Endocrinol Metab,2002,87: 5662-5667.

　　［10］ NISHIDA K,OKADA Y, NAWATA M,et al.Induction of hyperadiponectinemia following long?term treatment of patients with rheumatoid arthritis with infliximab (IFX),an anti?TNF?alpha antibody［J］. J Endocr,2008,55(1):213-216.

　　［11］ YANG W S, LEE W J, FUNAHASHI T,et al.Weight reduction increases plasma levels ofan adipose?derived anti?inflammatory protein,adiponectin［J］. J Clin Endocrinol Metab,2001,86:3815–3819.

　　［12］ FRUEBIS J, TSAO T S, JAORSCHI S,et al.Proteolytic cleavage product of 30?kDa adipocyte complement?related protein increases fatty acid oxidation in muscle and causes weight loss in mice［J］. Proc. Natl Acad Sci USA,2001,98:2005–2010.

　　［13］ ADAMCZAK M, WIECEK A, FUNAHASHI T, et al. Decreased plasma adiponectin concentration in patients with essential hypertension［J］.Am J Hypertens,2003,16:72-75.

　　［14］ TAKUYA I, MOTONOBU M, YOSHITO M,et al. Adiponectin levels associated with the development of hypertension:a prospective study［J］.Hypertens Res,2008, 31: 229–233.

　　［15］ MALLAMACI F, ZOCALI C, CUZZOLA F,et al. Adiponectin in essential hypertension［J］. J Nephrol,2002,15:507-511.

　　［16］ YANG W S, LEE W J. Plasma adiponectin levels in overweight and obese Asians［J］.Obesity research,2002,10(11):1104 -1101.

　　［17］ KUBOTA N, TERAUCHI Y, YAMAUCHI T,et al.Disruption of adiponectin causes insulin resistance and neointimal formation［J］. J Biol Chem,2002,277: 25863–25866.

　　［18］ MAEDA N, TAKAHASHI M, FUNAHASHI T,et al. PPAR?γ ligands increase expression and plasma concentrations of adiponectin, an adipose?derived protein［J］. Diabetes,2001,50:2094–2099.

　　［19］ BARTH N, LANGMANN T, SCHOLMERICH J,et al.Identification of regulatory elements in the human adipose most abundant gene transcript?1 (apM?1)promoter: role of SP1/SP3 and TNF?α as regulatory pathways［J］. Diabetologia,2002,45:1425–1433.

　　［20］ COMBS T P, WAGNER J A, BERGER J,et al.Induction of adipocyte complement?related protein of 30 kilodaltons by PPAR?γ agonists: a potential mechanism of insulin sensitization［J］. Endocrinology,2002,143:998–1007.